PIONEER: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Avapritinib in Patients with Indolent or Smoldering Systemic Mastocytosis (SM) With Symptoms Inadequately Controlled by Standard Therapy

Cem Akin, Hanneke Oude Elberink, Jason Gotlib, Vito Sabato, Karin Hartmann, Sigurd Broesby-Olsen, Mariana Castells, Michael Deininger, Mark Heaney, Tracy George, Deepti Radia, Massimo Triggiani, Paul van Daele, Daniel DeAngelo, Oleg Schmidt-Kittler, Hui-Min Lin, Andrew Morrison, Brenton Mar, Frank Sibenhaar, Marcus Maurer

Research output: Contribution to journalConference abstract in journalResearch

Original languageUndefined/Unknown
JournalJournal of Allergy and Clinical Immunology
Issue numberSuppl. 2
Pages (from-to)AB336
Publication statusPublished - 2020
EventAmerican Academy of Allergy Asthma & Immunology - San Diego, United States
Duration: 26. Feb 20201. Mar 2020


ConferenceAmerican Academy of Allergy Asthma & Immunology
Country/TerritoryUnited States
CitySan Diego
Internet address

Cite this